Cargando…
Activation of mTORC1 Signaling Cascade in Hippocampus and Medial Prefrontal Cortex Is Required for Antidepressant Actions of Vortioxetine in Mice
BACKGROUND: Although thought of as a multimodal-acting antidepressant targeting the serotonin system, more molecules are being shown to participate in the antidepressant mechanism of vortioxetine. A previous report has shown that vortioxetine administration enhanced the expression of rapamycin compl...
Autores principales: | Li, Wei-Yu, Shi, Tian-Shun, Huang, Jie, Chen, Yan-Mei, Guan, Wei, Jiang, Bo, Wang, Cheng-Niu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586031/ https://www.ncbi.nlm.nih.gov/pubmed/37025079 http://dx.doi.org/10.1093/ijnp/pyad017 |
Ejemplares similares
-
Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response
por: Papp, Mariusz, et al.
Publicado: (2021) -
M2-AChR Mediates Rapid Antidepressant Effects of Scopolamine Through Activating the mTORC1-BDNF Signaling Pathway in the Medial Prefrontal Cortex
por: Liu, Shuang, et al.
Publicado: (2021) -
The endogenous opioid system in the medial prefrontal cortex mediates ketamine’s antidepressant-like actions
por: Pittenger, Christopher, et al.
Publicado: (2023) -
Role of 5-HT(1A) Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
por: Fukumoto, Kenichi, et al.
Publicado: (2017) -
Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial
por: Mills, Natalie T, et al.
Publicado: (2020)